Current Drug Targets
Title:Editorial (Thematic Issue: Embryonic Signaling Pathways as Potential Targets for the Treatment of Rhabdomyosarcoma)
Volume: 17 Issue: 11
Author(s): Soledad Gallego and Josep Roma
Affiliation:
Export Options
About this article
Cite this article as:
Gallego Soledad and Roma Josep, Editorial (Thematic Issue: Embryonic Signaling Pathways as Potential Targets for the Treatment of Rhabdomyosarcoma), Current Drug Targets 2016; 17 (11) . https://dx.doi.org/10.2174/1389450117999160304150144
DOI https://dx.doi.org/10.2174/1389450117999160304150144 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
32
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Pixuvri<sup>®</sup> (Pixantrone Dimaleate, BBR 2778): From Lab to Market
Current Organic Chemistry NBN Polymorphysms and Cancer Susceptibility: A Systematic Review
Current Genomics Effects and Role of Multikinase Inhibitors in Thyroid Cancer
Current Pharmaceutical Design Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
Current Drug Targets Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma
Current Cancer Drug Targets HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
Anti-Cancer Agents in Medicinal Chemistry Dose-Intensive Chemotherapy with Stem Cell Support as a Treatment Strategy for Bone and Soft-Tissue Sarcomas
Current Stem Cell Research & Therapy IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design Circadian Timekeeping in Anticancer Therapeutics: An Emerging Vista of Chronopharmacology Research
Current Drug Metabolism GLUT4 Goes Abnormal: Disregulation of the Insulin-Responsive Glucose Transporter in Abnormal Metabolic States
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Oncolytic Coxsackievirus and the Mechanisms of its Effects on Cancer: A Narrative Review
Current Cancer Therapy Reviews miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Current Genomics Medicinal Plants and Cancer Chemoprevention
Current Drug Metabolism Functional Evaluation of an Ectopic Supernumerary Kidney in Pelvis
Current Medical Imaging Targeting Angiogenesis in Soft Tissue Sarcomas
Current Angiogenesis (Discontinued) Electrochemotherapy as First Line Cancer Treatment: Experiences from Veterinary Medicine in Developing Novel Protocols
Current Cancer Drug Targets The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews